Skip to main content
ACBT logo

ACBT — Investor Relations & Filings

Ticker · 4148 ISIN · KYG0232P1072 TW Manufacturing
Filings indexed 1,179 across all filing types
Latest filing 2019-05-09 Fund Information / Fact…
Country TW Taiwan
Listing TW 4148

About ACBT

www.allcosmos.com

All Cosmos Bio-Tech Holding Corporation specializes in the application of microbiology to develop and manufacture high-performance bio-chemical fertilizers. Its core products utilize a proprietary formulation combining organic matter, beneficial microorganisms, and chemical elements to enhance soil health and productivity. The company also engages in waste reutilization, applying biotechnological processes to convert organic waste into sustainable resources, and conducts research and development of microbial strains for health care and pharmaceutical applications. By leveraging advanced microbial R&D, the organization provides solutions designed to reduce reliance on traditional chemical inputs and promote circular economy principles. Its activities focus on the synthesis of biological and chemical technologies to provide sustainable alternatives for soil management and resource recovery.

Recent filings

Filing Released Lang Actions
108年4月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief financial summary table showing monthly and cumulative net operating revenue figures for a company (全宇生技-KY) for the period 民國108年04月 (April 2019). It contains no detailed financial statements or comprehensive analysis, only summarized revenue data. The document length is very short (649 characters), and it does not present a full financial report but rather a snapshot of financial data. This matches the description of a Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info. It is not an Annual Report, Interim Report, or Earnings Release because it lacks detailed financial statements or narrative analysis. It is not a Regulatory Filing or Report Publication Announcement because it contains actual financial data, not just an announcement. Therefore, the best classification is FS with high confidence.
2019-05-09 Chinese
108年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company, 全宇生技-KY, providing data on loan balances and guarantee information for the current and previous months, including limits and cumulative amounts. The content is concise, numerical, and relates to financial guarantees and loans but does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of financial status rather than a full report or announcement of a report. Given the short length (632 characters) and the nature of the data, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2019-05-09 Chinese
108年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledges by insiders and related parties of the company 全宇生技控股有限公司. It lists shareholdings of directors, independent directors, managers, and major shareholders, including pledged shares and percentages. The document does not contain financial statements, earnings data, or management discussion. It is a disclosure of insider shareholdings and pledges, which corresponds to a Director's Dealing or insider shareholding report. Given the nature of the data and the focus on insider holdings, the most appropriate classification is Director's Dealing (DIRS). The document length is 3078 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2019-05-08 Chinese
108年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties, with specific numbers of shares held, changes in holdings, and classifications of share types. It includes information about the identities and shareholdings of company insiders and related persons. There is no indication of financial statements, earnings data, legal proceedings, or meeting materials. The content matches the description of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is lengthy and detailed, not a brief announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2019-05-08 Chinese
108年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company, 全宇生技-KY, providing details on loan balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. The content is a regulatory financial update related to credit and guarantee exposures, but it does not contain comprehensive financial statements or detailed analysis typical of annual or interim reports. The document length is short (631 characters), and it appears to be a routine regulatory disclosure rather than a full report or announcement of a report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory disclosures that do not fit other categories.
2019-04-10 Chinese
108年3月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a financial summary report showing consolidated net operating revenue for a specific month (March 2019) and year-to-date figures, with comparisons to the previous year. It includes currency conversion rates and explanations for revenue changes. The document length is short (711 characters) and it primarily provides summarized financial data without detailed financial statements or comprehensive analysis. It does not appear to be a full interim or annual report, nor an earnings release with key highlights. It is more of a brief financial summary or factsheet. Given the short length and summary nature, it fits best under Fund Information / Factsheet (FS).
2019-04-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.